Conference Agenda – 29 October 2025
Time
Title
08:15–09:00
Registration and Welcome Coffee
09:00–09:05
Opening Remarks from Novartis
.-
09:00–09:05
Welcome and Introduction:
Valeria De Luca, Novartis (Chair)
Session 1:
AI in Clinical Development
09:05–09:10
Introduction to Session 1
Moderator: Valeria De Luca
09:10–09:30
Keynote
Maxwell Lawson, Novartis
09:30–09:50
Waheed Jowiya and Louisa Lind Skov, Novo Nordisk
09:50–10:10
Eric Durand, Owkin / Bioptimus
10:10–10:30
Panel and Q&A
Moderator: Valeria De Luca
Panel: Maxwell Lawson, Waheed Jowiya, Lousie Lind Skov and Eric Durand
10:30–11:00
Networking Break
Session 2:
AI to Scale Precision Medicine
11:00–11:05
Introduction to Session 2
Moderator: Jelena Curcic, Novartis
11:05–11:25
Julia Vogt, ETH
11:25–11:45
Following soon
11:45–12:05
Jörg Degen, Roche
12:05–12:35
Panel and Q&A
Moderator: Jelena Curcic,
Panel: Julia Vogt, Jörg Degen, TBA
12:35–13:35
Networking Break - Lunch
Session 3:
Event Partner Session
13:35–13:50
Jiajie Zhang, Evinova
13:50–14:05
Amazon Web Services
14:05–14:20
IQVIA
14:20–14:35
Andrew McKinnon, Medable
14:35–15:00
Networking Break
Session 4: Lightning Talks
AI in Clinical Trials: Regulatory Success Stories
15:00–15:05
Introduction to Session 3
Moderator: Alette Hunt, Novartis
15:05–15:15
AI Policy: What does it mean for Clinical Trials?
Thomas Brookland, Roche
15:15–15:25
Implementing genAI in Regulatory Affairs:
a Bayer experience
Paul Bolot, Bayer
15:25–15:35
Lightning Talk 3
Rebecca Lumsden, Sanofi
15:35–16:00
Panel and Q&A
Moderator: Alette Hunt
Panel: Thomas Brookland, Paul Bolot, Rebecca Lumsden
16:00–16:30
Key Note
Novartis
16:30–16:40
Closing Remarks
16:40–17:40
Networking Apéro
Venue
29–10–2025